Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.

PloS one - 1 Jan 2016

Sjöblom Liisa, Saramäki Outi, Annala Matti, Leinonen Katri, Nättinen Janika, Tolonen Teemu, Wahlfors Tiina, Nykter Matti, Bova G Steven, Schleutker Johanna, Tammela Teuvo L J, Lilja Hans, Visakorpi Tapio

Abstract excerpt

Microseminoprotein-beta (MSMB, MSMB) is an abundant secretory protein contributed by the prostate, and is implicated as a prostate cancer (PC) biomarker based on observations of its lower expression in cancerous cells compared with benign prostate epithelium. However, as the current literature on MSMB is inconsistent, we assessed the expression of MSMB at the protein and mRNA levels in a comprehensive set of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgens
Share to Biopsy, Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Neoplasm Recurrence, Local

Share to Prostatectomy

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms, Castration-Resistant

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 26939004
DOI: 10.1371/journal.pone.0150241
PMCID: PMC4777373

Genes

MSMB
NCOA4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.PMID 26939004Read ↗

The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.Semantic proximity Read ↗

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.Semantic proximity Read ↗

Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.Semantic proximity Read ↗

Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.Semantic proximity Read ↗

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.Semantic proximity Read ↗

Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate CancerSemantic proximity Read ↗

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.Semantic proximity Read ↗

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.Semantic proximity Read ↗

A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk.Semantic proximity Read ↗

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.Semantic proximity Read ↗

Mutation analysis of the MSMB gene in familial prostate cancer.Semantic proximity Read ↗

Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.